Fla. Stat. 465.0235
Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing


(1)

A pharmacy may provide pharmacy services to a long-term care facility or hospice licensed under chapter 400 or chapter 429 or a state correctional institution operated under chapter 944 through the use of an automated pharmacy system that need not be located at the same location as the pharmacy.

(2)

A community pharmacy, as defined in s. 465.003 and licensed in this state, may provide pharmacy services for outpatient dispensing through the use of an automated pharmacy system that need not be located at the same location as the community pharmacy if:The automated pharmacy system is under the supervision and control of the community pharmacy.The automated pharmacy system is housed in an indoor environment area and in a location to increase patients’ access to their prescriptions, including, but not limited to, medical facilities or places of business where essential goods and commodities are sold or large employer workplaces or locations where access to a community pharmacy is limited.The community pharmacy providing services through the automated pharmacy system notifies the board of the location of the automated pharmacy system and any changes in such location.The automated pharmacy system has a mechanism that provides live, real-time patient counseling by a pharmacist, as defined in s. 465.003 and licensed in this state, before the dispensing of any medicinal drug.The automated pharmacy system does not contain or dispense any controlled substance listed in s. 893.03 or 21 U.S.C. s. 812.The community pharmacy maintains a record of the medicinal drugs dispensed, including the identity of the pharmacist responsible for verifying the accuracy of the dosage and directions and providing patient counseling.The automated pharmacy system ensures the confidentiality of personal health information.The community pharmacy maintains written policies and procedures to ensure the proper, safe, and secure functioning of the automated pharmacy system. The community pharmacy shall annually review the policies and procedures and maintain a record of such policies and procedures for a minimum of 4 years. The annual review must be documented in the community pharmacy’s records and must be made available to the board upon request. The policies and procedures must, at a minimum, address all of the following:
Maintaining the automated pharmacy system and any accompanying electronic verification process in good working order.
Ensuring the integrity of the automated pharmacy system’s drug identifier database and its ability to identify the person responsible for making database entries.
Ensuring the accurate filling, stocking, restocking, and verification of the automated pharmacy system.
Ensuring the sanitary operation of the automated pharmacy system and the prevention of cross-contamination of cells, cartridges, containers, cassettes, or packages.
Testing the accuracy of the automated pharmacy system and any accompanying electronic verification process. The automated pharmacy system and accompanying electronic verification process must, at a minimum, be tested before the first use of the system, upon restarting the system, and after a modification of the system or electronic verification process which alters the filling, stocking, or restocking of the system or the electronic verification process.
Training of persons authorized to access, stock, restock, or use the system.
Conducting routine and preventative maintenance of the automated pharmacy system, including calibration of the system, if applicable.
Removing expired, adulterated, misbranded, or recalled medicinal drugs from the automated pharmacy system.
Preventing unauthorized persons from accessing the automated pharmacy system, including assigning, discontinuing, or modifying security access.
Identifying and recording persons responsible for filling, stocking, and restocking the automated pharmacy system.
Ensuring compliance with state and federal law, including, but not limited to, all applicable labeling, storage, and security requirements.
Maintaining an ongoing quality assurance program that monitors and records performance of the automated pharmacy system and any accompanying electronic verification process to ensure proper and accurate functioning, including tracking and documenting system errors. A community pharmacy must maintain such records for a minimum of 4 years and must make such records available to the board upon request.

(a)

The automated pharmacy system is under the supervision and control of the community pharmacy.

(b)

The automated pharmacy system is housed in an indoor environment area and in a location to increase patients’ access to their prescriptions, including, but not limited to, medical facilities or places of business where essential goods and commodities are sold or large employer workplaces or locations where access to a community pharmacy is limited.

(c)

The community pharmacy providing services through the automated pharmacy system notifies the board of the location of the automated pharmacy system and any changes in such location.

(d)

The automated pharmacy system has a mechanism that provides live, real-time patient counseling by a pharmacist, as defined in s. 465.003 and licensed in this state, before the dispensing of any medicinal drug.

(e)

The automated pharmacy system does not contain or dispense any controlled substance listed in s. 893.03 or 21 U.S.C. s. 812.

(f)

The community pharmacy maintains a record of the medicinal drugs dispensed, including the identity of the pharmacist responsible for verifying the accuracy of the dosage and directions and providing patient counseling.

(g)

The automated pharmacy system ensures the confidentiality of personal health information.

(h)

The community pharmacy maintains written policies and procedures to ensure the proper, safe, and secure functioning of the automated pharmacy system. The community pharmacy shall annually review the policies and procedures and maintain a record of such policies and procedures for a minimum of 4 years. The annual review must be documented in the community pharmacy’s records and must be made available to the board upon request. The policies and procedures must, at a minimum, address all of the following:Maintaining the automated pharmacy system and any accompanying electronic verification process in good working order.Ensuring the integrity of the automated pharmacy system’s drug identifier database and its ability to identify the person responsible for making database entries.Ensuring the accurate filling, stocking, restocking, and verification of the automated pharmacy system.Ensuring the sanitary operation of the automated pharmacy system and the prevention of cross-contamination of cells, cartridges, containers, cassettes, or packages.Testing the accuracy of the automated pharmacy system and any accompanying electronic verification process. The automated pharmacy system and accompanying electronic verification process must, at a minimum, be tested before the first use of the system, upon restarting the system, and after a modification of the system or electronic verification process which alters the filling, stocking, or restocking of the system or the electronic verification process.Training of persons authorized to access, stock, restock, or use the system.Conducting routine and preventative maintenance of the automated pharmacy system, including calibration of the system, if applicable.Removing expired, adulterated, misbranded, or recalled medicinal drugs from the automated pharmacy system.Preventing unauthorized persons from accessing the automated pharmacy system, including assigning, discontinuing, or modifying security access.Identifying and recording persons responsible for filling, stocking, and restocking the automated pharmacy system.Ensuring compliance with state and federal law, including, but not limited to, all applicable labeling, storage, and security requirements.Maintaining an ongoing quality assurance program that monitors and records performance of the automated pharmacy system and any accompanying electronic verification process to ensure proper and accurate functioning, including tracking and documenting system errors. A community pharmacy must maintain such records for a minimum of 4 years and must make such records available to the board upon request.
1. Maintaining the automated pharmacy system and any accompanying electronic verification process in good working order.
2. Ensuring the integrity of the automated pharmacy system’s drug identifier database and its ability to identify the person responsible for making database entries.
3. Ensuring the accurate filling, stocking, restocking, and verification of the automated pharmacy system.
4. Ensuring the sanitary operation of the automated pharmacy system and the prevention of cross-contamination of cells, cartridges, containers, cassettes, or packages.
5. Testing the accuracy of the automated pharmacy system and any accompanying electronic verification process. The automated pharmacy system and accompanying electronic verification process must, at a minimum, be tested before the first use of the system, upon restarting the system, and after a modification of the system or electronic verification process which alters the filling, stocking, or restocking of the system or the electronic verification process.
6. Training of persons authorized to access, stock, restock, or use the system.
7. Conducting routine and preventative maintenance of the automated pharmacy system, including calibration of the system, if applicable.
8. Removing expired, adulterated, misbranded, or recalled medicinal drugs from the automated pharmacy system.
9. Preventing unauthorized persons from accessing the automated pharmacy system, including assigning, discontinuing, or modifying security access.
10. Identifying and recording persons responsible for filling, stocking, and restocking the automated pharmacy system.
11. Ensuring compliance with state and federal law, including, but not limited to, all applicable labeling, storage, and security requirements.
12. Maintaining an ongoing quality assurance program that monitors and records performance of the automated pharmacy system and any accompanying electronic verification process to ensure proper and accurate functioning, including tracking and documenting system errors. A community pharmacy must maintain such records for a minimum of 4 years and must make such records available to the board upon request.

(3)

Medicinal drugs stored in bulk or unit of use in an automated pharmacy system servicing a long-term care facility, hospice, or correctional institution, or for outpatient dispensing, are part of the inventory of the pharmacy providing pharmacy services to that facility, hospice, or institution, or for outpatient dispensing, and medicinal drugs delivered by the automated pharmacy system are considered to have been dispensed by that pharmacy.

(4)

The operation of an automated pharmacy system must be under the supervision of a pharmacist licensed in this state. To qualify as a supervisor for an automated pharmacy system, the pharmacist need not be physically present at the site of the automated pharmacy system and may supervise the system electronically. The pharmacist shall be required to develop and implement policies and procedures designed to verify that the medicinal drugs delivered by the automated pharmacy system are accurate and valid and that the machine is properly restocked.

(5)

The Legislature does not intend for this section to limit the current practice of pharmacy in this state. This section is intended to allow automated pharmacy systems to enhance the ability of a pharmacist to provide pharmacy services in locations that do not employ a full-time pharmacist. This section does not limit or replace the use of a consultant pharmacist.

(6)

The board may adopt rules governing the use of automated pharmacy systems. If adopted, such rules must include all of the following:Recordkeeping requirements.Security requirements.Labeling requirements that permit the use of unit-dose medications if the facility, hospice, or institution maintains medication-administration records that include directions for use of the medication and the automated pharmacy system identifies:
The dispensing pharmacy.
The prescription number.
The name of the patient.
The name of the prescribing practitioner.

(a)

Recordkeeping requirements.

(b)

Security requirements.

(c)

Labeling requirements that permit the use of unit-dose medications if the facility, hospice, or institution maintains medication-administration records that include directions for use of the medication and the automated pharmacy system identifies:The dispensing pharmacy.The prescription number.The name of the patient.The name of the prescribing practitioner.
1. The dispensing pharmacy.
2. The prescription number.
3. The name of the patient.
4. The name of the prescribing practitioner.

Source: Section 465.0235 — Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing, https://www.­flsenate.­gov/Laws/Statutes/2024/0465.­0235 (accessed Aug. 7, 2025).

465.001
Short Title
465.002
Legislative findings
465.003
Definitions
465.004
Board of Pharmacy
465.005
Authority to make rules
465.006
Disposition of fees
465.007
Licensure by examination
465.008
Renewal of license
465.009
Continuing professional pharmaceutical education
465.012
Reactivation of license
465.013
Registration of pharmacy interns
465.014
Pharmacy technician
465.015
Violations and penalties
465.016
Disciplinary actions
465.017
Authority to inspect
465.018
Community pharmacies
465.019
Institutional pharmacies
465.022
Pharmacies
465.023
Pharmacy permittee
465.024
Promoting sale of certain drugs prohibited
465.025
Substitution of drugs
465.026
Filling of certain prescriptions
465.027
Exceptions
465.035
Dispensing of medicinal drugs pursuant to facsimile of prescription
465.0075
Licensure by endorsement
465.0125
Consultant pharmacist license
465.0126
Nuclear pharmacist license
465.0155
Standards of practice
465.0156
Registration of nonresident pharmacies
465.0157
International export pharmacy permit
465.0158
Nonresident sterile compounding permit
465.0161
Distribution of medicinal drugs without a permit
465.0181
Community pharmacy permit required to dispense Schedule II or Schedule III controlled substances
465.185
Rebates prohibited
465.186
Pharmacist’s order for medicinal drugs
465.187
Sale of medicinal drugs
465.188
Medicaid audits of pharmacies
465.189
Administration of vaccines and epinephrine autoinjection
465.0193
Nuclear pharmacy permits
465.0196
Special pharmacy permits
465.0197
Internet pharmacy permits
465.0235
Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing
465.0244
Information disclosure
465.0251
Generic drugs
465.0252
Substitution of interchangeable biosimilar products
465.0255
Expiration date of medicinal drugs
465.0265
Centralized prescription filling
465.0266
Common database
465.0275
Emergency prescription refill
465.0276
Dispensing practitioner
465.1861
Ordering and dispensing HIV infection prevention drugs
465.1865
Collaborative pharmacy practice for chronic health conditions
465.1893
Administration of antipsychotic medication by injection
465.1895
Testing or screening for and treatment of minor, nonchronic health conditions
465.1901
Practice of orthotics and pedorthics
465.1902
Prescription Drug Donation Repository Program

Current through Fall 2025

§ 465.0235. Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing's source at flsenate​.gov